MICHELLE A LEVY M.D. NPI 1851667596

NPI Information

  • NPI: 1851667596
  • Provider Name: MICHELLE A LEVY, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1800 N WILLIAMS ST STE 200
    DENVER, CO
    ZIP 80218
  • Phone: (303) 388-4876

Map and Directions

Get Directions

NPI Details

Michelle A Levy, M.D. is a hematology and oncology internal medicine in Denver, CO with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Michelle A Levy, M.D. NPI is 1851667596. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: EMORY UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2012

The provider's business location address is:

1800 N WILLIAMS ST STE 200
DENVER, CO
ZIP 80218-237
Phone: (303) 388-4876
Fax: (303) 285-5097

The NPI 1851667596 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, lanreotide, 1 mg (HCPCS:J1930)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Gallium ga-68, dotatate, diagnostic, 0.1 millicurie (HCPCS:A9587)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Red blood count, automated test (HCPCS:85045)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Uric acid level, blood (HCPCS:84550)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Magnesium level (HCPCS:83735)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Phosphate level (HCPCS:84100)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • Radioactive drug therapy through a vein (HCPCS:79101)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 3/27/2012 and was last updated on 2/17/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1390200000XStudent in an Organized Health Care Education/Training ProgramNo
2207RH0003XInternal MedicineHematology & OncologyDR.0060319COLORADOYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.